This document summarizes a study examining whether direct-to-consumer advertising leads to stimulated adverse event reporting on social media. The study analyzed over 4,000 potential adverse event reports related to 58 pharmaceutical products mentioned on Twitter between 2014-2015. It found higher rates of potential adverse event reports per 1,000 Twitter users and per 1,000 product mentions in the United States compared to the United Kingdom, Canada, and Australia. The study aims to understand the relationship between direct-to-consumer advertising and adverse event reporting on social media.